Literature DB >> 13926331

The concurrent weekly administration of chloroquine and primaquine for the prevention of Korean vivax malaria.

S VIVONA, G J BREWER, M CONRAD, A S ALVING.   

Abstract

Entities:  

Keywords:  ANTIMALARIALS/therapy; CHLOROQUINE/therapy

Mesh：

Substances：

Year:  1961        PMID： 13926331      PMCID： PMC2555555     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN： 0042-9686            Impact factor:   9.408


× No keyword cloud information.
  9 in total

1.  Erythrocyte glucose-6-phosphate dehydrogenase deficiency: evidence of differences between Negroes and Caucasians with respect to this genetically determined trait.

Authors:  P A MARKS; R T GROSS
Journal:  J Clin Invest       Date:  1959-12       Impact factor: 14.808

2.  A study of subjects with erythrocyte glucose-6-phosphate dehydrogenase deficiency. II. Investigation of leukocyte enzymes.

Authors:  B RAMOT; S FISHER; A SZEINBERG; A ADAM; C SHEBA; D GAFNI
Journal:  J Clin Invest       Date:  1959-12       Impact factor: 14.808

3.  A study of subjects with erythrocyte glucose-6-phosphate dehydrogenase deficiency: investigation of platelet enzymes.

Authors:  B RAMOT; A SZEINBERG; A ADAM; C SHEBA; D GAFNI
Journal:  J Clin Invest       Date:  1959-09       Impact factor: 14.808

4.  A modification of the benzidine method for measurement of hemoglobin in plasma and urine.

Authors:  W H CROSBY; F W FURTH
Journal:  Blood       Date:  1956-04       Impact factor: 22.113

5.  The hemolytic effect of primaquine. VI. An in vitro test for sensitivity of erythrocytes to primaquine.

Authors:  E BEUTLER; R J DERN; A S ALVING
Journal:  J Lab Clin Med       Date:  1955-01

6.  Mass antimalarial therapy in veterans returning from Korea.

Authors:  C P ARCHAMBEAULT
Journal:  J Am Med Assoc       Date:  1954-04-24

7.  Further studies on the properties and assay of glucose 6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase of rat liver.

Authors:  G E GLOCK; P McLEAN
Journal:  Biochem J       Date:  1953-10       Impact factor: 3.857

8.  Mitigation of the haemolytic effect of primaquine and enhancement of its action against exoerythrocytic forms of the Chesson strain of Piasmodium vivax by intermittent regimens of drug administration: a preliminary report.

Authors:  A S ALVING; C F JOHNSON; A R TARLOV; G J BREWER; R W KELLERMEYER; P E CARSON
Journal:  Bull World Health Organ       Date:  1960       Impact factor: 9.408

9.  Methaemoglobin reduction test: a new, simple, in vitro test for identifying primaquine-sensitivity.

Authors:  G J BREWER; A R TARLOV; A S ALVING
Journal:  Bull World Health Organ       Date:  1960       Impact factor: 9.408
  9 in total
  5 in total

1.  Malaria: An Unsolved Military Medical Problem.

Authors:  R E Blount
Journal:  Trans Am Clin Climatol Assoc       Date:  1964

Review 2.  Resistance to therapies for infection by Plasmodium vivax.

Authors:  J Kevin Baird
Journal:  Clin Microbiol Rev       Date:  2009-07       Impact factor: 26.132

Review 3.  Antimalarial drug toxicity: a review.

Authors:  W Robert J Taylor; Nicholas J White
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

Review 4.  Management of relapsing Plasmodium vivax malaria.

Authors:  Cindy S Chu; Nicholas J White
Journal:  Expert Rev Anti Infect Ther       Date:  2016-08-31       Impact factor: 5.091

5.  Primaquine at alternative dosing schedules for preventing relapse in people with Plasmodium vivax malaria.

Authors:  Rachael Milligan; André Daher; Patricia M Graves
Journal:  Cochrane Database Syst Rev       Date:  2019-07-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.